NCT00683930 - A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Pemphigus Vulgaris (PV)

Interventions

DRUG

Mycophenolate Mofetil 2 g/Day

Mycophenolate mofetil 500 mg tablets; 4 tablets twice daily for 52 weeks

DRUG

Mycophenolate Mofetil (MMF) 3 g/Day

Mycophenolate mofetil 500 mg tablets; 6 tablets twice daily for 52 weeks

DRUG

Placebo

Placebo for MMF 2 g/day group: 4 tablets orally twice daily for 52 weeks; placebo for MMF 3 g/day group: 6 tablets orally twice daily for 52 weeks

Trial Locations (26)

6100

Ankara

8091

Zurich

10010

New York

21205

Baltimore

30033

Atlanta

31096

Haifa

48149

Münster

49100

Petah Tikva

50937

Cologne

55131

Mainz

60596

Frankfurt am Main

63110

St Louis

69115

Heidelberg

83099

Donetsk

88011

Uzhhorod

89081

Ulm

90095

Los Angeles

95006

Crimea

252151

Kiev

M5T 3A9

Toronto

H3G 1C6

Montreal

Unknown

Ankara

Istanbul

Lugnansk

LE1 5WW

Leicester

SE1 7EH

London